Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.33	9.29	13.52	14.85	10.29	9.65
Cash & Short-Term Investments	4.33	9.29	13.52	14.85	10.29	9.65
Cash Growth	-83.61%	-31.30%	-8.95%	44.36%	6.62%	59.94%
Other Receivables	2.17	0.74	3.36	8.53	2.99	0.56
Receivables	2.17	0.74	3.36	8.53	2.99	0.56
Prepaid Expenses	1.02	1.27	2.27	3.66	1.72	0.64
Total Current Assets	7.52	11.31	19.15	27.05	15	10.85
Property, Plant & Equipment	53.16	54.93	57.28	46.65	38.07	12.84
Goodwill	3.49	3.49	3.49	3.49	3.49	3.49
Long-Term Deferred Charges	10.26	10.26	10.26	10.26	10.26	10.26
Other Long-Term Assets	6.36	6.46	8.19	8.39	2.96	2.09
Total Assets	80.79	86.44	98.36	95.83	69.77	39.52
Accounts Payable	0.97	0.77	1.59	1.68	1.14	0.96
Accrued Expenses	2.16	3.57	4.87	6.18	2.17	1.54
Short-Term Debt	-	-	-	-	-	0.72
Current Portion of Long-Term Debt	112.34	38.95	-	-	-	-
Current Portion of Leases	4.49	4.43	9.48	17.01	1.51	1.55
Other Current Liabilities	0.14	0.53	0.52	-	-	1.94
Total Current Liabilities	120.09	48.25	16.46	24.87	4.81	6.71
Long-Term Debt	-	55.44	82.31	-	-	-
Long-Term Leases	27.13	27.69	28.58	31.8	36.48	10.88
Long-Term Deferred Tax Liabilities	3.08	3.08	3.08	3.08	3.08	3.08
Total Liabilities	150.29	134.46	130.43	59.75	44.37	20.66
Common Stock	0.36	0.36	0.36	0.36	0.27	0.19
Additional Paid-In Capital	280.7	279.35	276.39	275.49	227.98	198.37
Retained Earnings	-350.56	-327.74	-308.82	-239.77	-202.86	-179.7
Shareholders' Equity	-69.5	-48.02	-32.07	36.08	25.4	18.86
Total Liabilities & Equity	80.79	86.44	98.36	95.83	69.77	39.52
Total Debt	143.96	126.52	120.37	48.82	37.99	13.15
Net Cash (Debt)	-139.63	-117.22	-106.85	-33.96	-27.7	-3.5
Net Cash Per Share	-3.86	-1.98	-2.96	-0.99	-1.15	-0.21
Filing Date Shares Outstanding	36.23	36.18	36.15	36.14	30.73	24.94
Total Common Shares Outstanding	36.19	36.18	36.12	36.14	27.11	18.69
Working Capital	-112.57	-36.94	2.69	2.17	10.18	4.14
Book Value Per Share	-1.92	-1.33	-0.89	1.00	0.94	1.01
Tangible Book Value	-72.99	-51.51	-35.56	32.59	21.91	15.37
Tangible Book Value Per Share	-2.02	-1.42	-0.98	0.90	0.81	0.82
Machinery	22.74	14.29	12.83	11.27	9.02	7.68
Construction In Progress	-	8.3	8.1	-	-	-
Leasehold Improvements	3.8	3.8	3.45	3.45	3.42	3.42

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q